Profile data is unavailable for this security.
About the company
ICU Medical, Inc. develops, manufactures, and sells medical products used in infusion therapy, vascular access, and vital care applications. Its product portfolio includes ambulatory, syringe, and large volume IV pumps and safety software; dedicated and non-dedicated IV sets, needlefree IV connectors, peripheral IV catheters, and sterile IV solutions; closed system transfer devices and pharmacy compounding systems; as well as a range of respiratory, anesthesia, patient monitoring, and temperature management products. Its Infusion Therapy products include Clave needlefree products, Neutron, ClearGuard, and Tego. Its oncology products include ChemoLock Closed System Transfer Devices (CSTD) and Deltec GRIPPER non-coring needles for portal access. Its vascular access products include Safe-T Wing venipuncture and blood collection devices; Port-A-Cath implantable port, and Portex arterial blood sampling syringes. Its Tracheostomy products include Portex BLUselect PVC tracheostomy tubes.
- Revenue in USD (TTM)2.23bn
- Net income in USD732.00k
- Incorporated1992
- Employees13.00k
- LocationICU Medical Inc951 Calle AmanecerSAN CLEMENTE 92673United StatesUSA
- Phone+1 (949) 366-2183
- Fax+1 (949) 366-8368
- Websitehttps://www.icumed.com/
More ▼
Peer analysis
Key Information
- Key Information
- Stock Performance
- Per Share Data
- Efficiency
- Management Effectiveness
- Profitability
- Financial Strength
- Growth Rates
| Company | Revenue (TTM) | Net income (TTM) | Market cap | Employees | Price/earnings (TTM) | Price/book value (MRQ) | Price/cash flow (TTM) | Price/sales (TTM) | EPS (excl. extraordinary items, TTM) | EPS (incl. extraordinary items, TTM) | Revenue per share (TTM) | Book value per share (MRQ) | Asset turnover (TTM) | Inventory turnover (TTM) | Receivables turnover (TTM) | Revenues per employee (TTM) | Return on avg assets (TTM) | Return on avg assets (5 yr avg) | Return on investment (TTM) | Return on investment (5 yr avg) | Gross margin (TTM) | Gross margin (5 yr avg) | Net profit margin (TTM) | Net Profit margin (5 yr avg) | Quick ratio (MRQ) | Interest coverage (TTM) | Total debt to capital (MRQ) | Payout ratio (5 yr avg) | Revenue (YOY change %) | Revenue (5 yr growth rate) | Net income (YOY change %) | Net income (5 yr growth rate) | Capital expenditure (5 yr growth rate) | Dividend (5 yr growth rate) |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Alphatec Holdings Inc | 764.16m | -143.36m | 2.06bn | 913.00 | -- | 164.70 | -- | 2.70 | -0.9598 | -0.9598 | 5.09 | 0.2398 | 0.9754 | 1.35 | 7.86 | 836,971.50 | -18.30 | -24.58 | -24.00 | -31.32 | 69.60 | 67.58 | -18.76 | -32.07 | 1.28 | -1.28 | 0.9402 | -- | 24.95 | 39.46 | 11.57 | -- | 16.50 | -- |
| Establishment Labs Holdings Inc | 211.08m | -51.06m | 2.29bn | 1.02k | -- | 97.12 | -- | 10.83 | -1.74 | -1.74 | 7.17 | 0.8104 | 0.5997 | 0.788 | 2.96 | -- | -14.51 | -27.03 | -18.45 | -33.98 | 69.32 | 66.79 | -24.19 | -39.79 | 2.00 | -1.29 | 0.9131 | -- | 27.14 | 20.04 | 39.64 | -- | -- | -- |
| Neogen Corp | 880.32m | -602.74m | 2.44bn | 2.97k | -- | 1.16 | -- | 2.77 | -2.78 | -2.78 | 4.05 | 9.67 | 0.2375 | 2.63 | 5.95 | 296,005.00 | -16.26 | -7.73 | -16.94 | -8.06 | 45.98 | 48.10 | -68.47 | -27.91 | 2.80 | -0.2109 | 0.2737 | -- | -3.20 | 16.43 | -11,491.59 | -- | 34.18 | -- |
| LeMaitre Vascular Inc | 249.60m | 57.73m | 2.46bn | 646.00 | 43.75 | 6.26 | 36.16 | 9.87 | 2.47 | 2.47 | 10.72 | 17.28 | 0.4276 | 1.05 | 7.84 | 386,380.80 | 9.89 | 9.27 | 10.49 | 9.98 | 71.53 | 67.70 | 23.13 | 18.33 | 10.95 | -- | 0.300 | 36.37 | 13.53 | 14.05 | 31.10 | 22.16 | 17.86 | 18.10 |
| DENTSPLY SIRONA Inc | 3.68bn | -598.00m | 2.93bn | 14.00k | -- | 2.19 | -- | 0.7968 | -3.00 | -3.00 | 18.44 | 6.71 | 0.6582 | 3.05 | 5.92 | 262,857.20 | -10.70 | -5.83 | -14.50 | -7.12 | 50.00 | 52.93 | -16.25 | -11.12 | 1.03 | 4.77 | 0.6347 | -- | -2.98 | 1.96 | 34.29 | -- | 8.53 | 9.86 |
| Haemonetics Corp | 1.32bn | 175.44m | 2.94bn | 3.02k | 17.40 | 3.25 | 10.22 | 2.23 | 3.64 | 3.64 | 27.40 | 19.46 | 0.525 | 1.58 | 6.47 | 436,081.70 | 6.99 | 5.41 | 8.30 | 6.55 | 59.32 | 53.20 | 13.31 | 9.18 | 1.15 | 12.69 | 0.5733 | 0.00 | 3.95 | 6.60 | 42.64 | 16.99 | 4.37 | -- |
| 10X Genomics Inc | 642.82m | -43.54m | 2.94bn | 1.18k | -- | 3.70 | -- | 4.58 | -0.3496 | -0.3496 | 5.15 | 6.24 | 0.6559 | 2.85 | 9.53 | 545,690.10 | -4.44 | -14.35 | -5.16 | -16.43 | 69.13 | 72.27 | -6.77 | -24.50 | 4.09 | -- | 0.00 | -- | 5.25 | 16.55 | 76.16 | -- | -31.16 | -- |
| Integer Holdings Corp | 1.85bn | 102.83m | 2.98bn | 11.00k | 30.17 | 1.70 | 12.77 | 1.61 | 2.87 | 2.87 | 52.83 | 50.85 | 0.5714 | 5.37 | 4.59 | -- | 3.17 | 3.26 | 3.41 | 3.51 | 27.39 | 26.88 | 5.55 | 6.07 | 2.23 | 6.04 | 0.41 | -- | 7.98 | 11.54 | -15.05 | 5.89 | 12.09 | -- |
| ICU Medical Inc | 2.23bn | 732.00k | 3.72bn | 13.00k | 6,101.30 | 1.75 | 18.18 | 1.67 | 0.0247 | 0.0247 | 90.50 | 86.03 | 0.5406 | 2.35 | 12.28 | 171,635.50 | 0.0465 | -0.6518 | 0.0534 | -0.7376 | 36.84 | 34.16 | 0.0861 | -1.11 | 1.15 | 1.70 | 0.378 | -- | -6.33 | 11.91 | 100.62 | -61.53 | -0.6816 | -- |
| LivaNova PLC | 1.39bn | -242.47m | 3.86bn | 3.30k | -- | 3.22 | -- | 2.78 | -4.47 | -4.47 | 25.37 | 21.96 | 0.543 | 2.84 | 6.79 | 420,622.10 | -9.48 | -3.21 | -12.39 | -3.97 | 68.04 | 68.27 | -17.46 | -6.55 | 1.16 | 3.67 | 0.2389 | -- | 10.74 | 8.24 | -483.45 | -- | 18.27 | -- |
| iRhythm Holdings, Inc | 747.14m | -44.55m | 4.32bn | 2.40k | -- | 28.28 | -- | 5.79 | -1.41 | -1.41 | 23.35 | 4.73 | 0.7657 | 12.33 | 9.60 | 311,307.50 | -4.57 | -16.40 | -5.28 | -19.65 | 70.57 | 68.67 | -5.96 | -19.44 | 4.48 | -- | 0.8096 | -- | 26.24 | 23.02 | 60.67 | -- | 27.88 | -- |
| Merit Medical Systems Inc | 1.52bn | 128.49m | 4.59bn | 7.50k | 36.31 | 2.89 | 18.00 | 3.03 | 2.13 | 2.13 | 25.07 | 26.66 | 0.594 | 2.43 | 7.70 | 202,120.80 | 5.03 | 4.56 | 5.53 | 5.10 | 48.70 | 46.73 | 8.48 | 7.34 | 2.95 | 16.77 | 0.3166 | 0.00 | 11.75 | 9.48 | 6.76 | -- | 11.48 | -- |
| Stevanato Group SpA | 1.38bn | 166.09m | 4.70bn | 5.52k | 25.51 | 2.49 | 17.74 | 3.40 | 0.6085 | 0.6085 | 5.07 | 6.22 | 0.5058 | 2.95 | 2.65 | 250,421.90 | 6.08 | 8.02 | 7.63 | 10.94 | 29.27 | 31.01 | 12.01 | 13.24 | 1.30 | 30.00 | 0.2386 | 6.82 | 1.72 | 15.53 | -19.13 | 24.61 | 33.52 | -- |
| Envista Holdings Corp | 2.72bn | 47.00m | 4.79bn | 12.00k | 106.23 | 1.54 | 29.37 | 1.76 | 0.275 | 0.275 | 16.10 | 18.96 | 0.4931 | 4.62 | 6.86 | 226,625.00 | 0.8523 | -2.14 | 1.01 | -2.58 | 55.02 | 56.70 | 1.73 | -5.21 | 2.04 | 6.70 | 0.318 | -- | 8.32 | 7.11 | 104.20 | 2.03 | -1.03 | -- |
| Lantheus Holdings Inc | 1.54bn | 233.56m | 4.84bn | 1.19k | 22.28 | 4.44 | 15.94 | 3.14 | 3.36 | 3.36 | 22.33 | 16.87 | 0.7328 | 9.04 | 4.53 | 1,292,212.00 | 11.10 | 11.26 | 12.85 | 12.98 | 61.10 | 61.61 | 15.15 | 14.47 | 2.51 | -- | 0.3432 | 0.00 | 0.5019 | 35.35 | -25.25 | -- | 23.67 | -- |
| TransMedics Group Inc | 605.49m | 188.99m | 4.98bn | 898.00 | 30.51 | 10.52 | 23.03 | 8.23 | 4.76 | 4.79 | 14.94 | 13.81 | 0.6467 | 5.09 | 6.65 | 674,269.50 | 20.19 | 4.75 | 21.93 | 5.18 | 59.92 | 61.27 | 31.21 | 8.52 | 6.59 | 84.70 | 0.5199 | 0.00 | 37.13 | 88.21 | 436.58 | -- | 164.81 | -- |
Data as of Feb 27 2026. Currency figures normalised to ICU Medical Inc's reporting currency: US Dollar USD
56.95%Per cent of shares held by top holders
| Holder | Shares | % Held |
|---|---|---|
| BlackRock Fund Advisorsas of 31 Dec 2025 | 3.28m | 13.29% |
| The Vanguard Group, Inc.as of 31 Dec 2025 | 2.51m | 10.18% |
| Janus Henderson Investors US LLCas of 31 Dec 2025 | 2.51m | 10.18% |
| Fuller & Thaler Asset Management, Inc.as of 31 Dec 2025 | 1.27m | 5.13% |
| SSgA Funds Management, Inc.as of 31 Dec 2025 | 942.67k | 3.82% |
| Dimensional Fund Advisors LPas of 31 Dec 2025 | 872.57k | 3.54% |
| Schroder Investment Management North America, Inc.as of 31 Dec 2025 | 765.40k | 3.10% |
| Columbia Management Investment Advisers LLCas of 31 Dec 2025 | 661.39k | 2.68% |
| River Road Asset Management LLCas of 31 Dec 2025 | 650.87k | 2.64% |
| Geode Capital Management LLCas of 31 Dec 2025 | 593.49k | 2.40% |
More ▼
Data from 31 Dec 2025 - 31 Dec 2025Source: FactSet Research Systems Inc.
